PFND vs JNJ: Which Stock is Better?
Side-by-side comparison of Pathfinder Cell Therapy Inc and Johnson & Johnson in 2026
PFND
Pathfinder Cell Therapy Inc
$0.00
JNJ
Johnson & Johnson
$230.69
Key Metrics Comparison
| Metric | PFND | JNJ | Winner |
|---|---|---|---|
| Market Cap | $0.07M | $564.35B | JNJ |
| P/E Ratio | N/A | 21.23 | JNJ |
| EPS (TTM) | $N/A | $11.03 | JNJ |
| Revenue Growth | 0.0% | 0.1% | JNJ |
| Gross Margin | 0.0% | 68.0% | JNJ |
Analyze PFND
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PFND or JNJ a better investment?
Comparing PFND and JNJ: Pathfinder Cell Therapy Inc has a market cap of $0.07M while Johnson & Johnson has $564.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PFND and JNJ?
PFND (Pathfinder Cell Therapy Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PFND or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PFND or JNJ?
JNJ has higher revenue growth at 0.1% vs 0.0% for PFND.
Which company is more profitable: PFND or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 0.0% for PFND.
Which is the larger company: PFND or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $564.35B compared to $0.07M for PFND.
Should I buy PFND or JNJ in 2026?
Both PFND and JNJ have investment merit. PFND trades at $0.00 while JNJ trades at $230.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PFND and JNJ stock?
Key differences: Market Cap ($0.07M vs $564.35B), P/E Ratio (N/A vs 21.2x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 68.0%).